Literature DB >> 9656409

Estimation of ASO titer as an indicator of streptococcal infection precipitating acute adenolymphangitis in brugian lymphatic filariasis.

T K Suma1, R K Shenoy, J Varghese, V V Kuttikkal, V Kumaraswami.   

Abstract

Recurrent episodes of acute adenolymphangitis (ADL) are important clinical manifestations of lymphatic filariasis which contribute significantly to the progression of lymphedema. It is increasingly being recognized that secondary bacterial infections play an important role in the etiology of ADL. We examined the role of streptococcal infection as a precipitating factor of ADL in brugian filariasis, by determining the anti-streptolysin O (ASO) titers and by isolating the causative organism wherever possible. The study population consisted of 30 patients with filariasis related ADL (Group A), 30 patients with chronic filarial edema (Group B) and 60 age and sex matched healthy adults (Group C). ASO titer was estimated by the latex agglutination method at the time of entry into the study, at the 15th day and at 3, 6 and 12 months. ASO titers were persistently elevated in 90% of patients in Group A and a portal of entry for bacterial infection was detected in all of these patients. In Group B only six patients had persistently elevated ASO titers. These patients had grade III lymphedema and three of them had monilial infections in the affected limb. In the control group none had persistently elevated ASO titers. The elevated ASO titers and the detection of a site of entry for bacteria in patients with ADL supports a streptococcal etiology for this condition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9656409

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  6 in total

1.  Clinical and pathological aspects of filarial lymphedema and its management.

Authors:  R K Shenoy
Journal:  Korean J Parasitol       Date:  2008-09       Impact factor: 1.341

2.  Management of ulcers in lymphoedematous limbs.

Authors:  Vishnu M Karnasula
Journal:  Indian J Plast Surg       Date:  2012-05

3.  Impact of basic lymphedema management and antifilarial treatment on acute dermatolymphangioadenitis episodes and filarial antigenaemia.

Authors:  Ha El-Nahas; Am El-Shazly; M Abulhassan; Na Nabih; N Mousa
Journal:  J Glob Infect Dis       Date:  2011-07

4.  Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature.

Authors:  David G Addiss; Molly A Brady
Journal:  Filaria J       Date:  2007-02-15

5.  Future Research Priorities for Morbidity Control of Lymphedema.

Authors:  S R Narahari; Madhur Guruprasad Aggithaya; Christine Moffatt; T J Ryan; Vaughan Keeley; B Vijaya; P Rajendran; S B Karalam; S Rajagopala; N K Kumar; K S Bose; K V Sushma
Journal:  Indian J Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.494

6.  Changes in Antibody Levels during and following an Episode of Acute Adenolymphangitis (ADL) among Lymphedema Patients in Léogâne, Haiti.

Authors:  Katherine E Mues; Patrick J Lammie; Mitchel Klein; David G Kleinbaum; David Addiss; LeAnne M Fox
Journal:  PLoS One       Date:  2015-10-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.